Dr. Michelle Tarver, a veteran of the Food and Drug Administration (FDA), has taken charge of the FDA’s device division at a ...

Musk has business interests that depend heavily on government regulation, subsidies or policy, from Tesla’s electric cars to ...

Neuralink's second brain implant shows promise as the company aims to enhance the quality of life for individuals with spinal ...

Science Corporation says its retinal implant restored central vision in patients who were legally blind in a clinical trial.

Michelle Tarver, MD, PhD, a 15-year veteran of the agency, is stepping into a pivotal role as the new director of the FDA's device division, taking over for Jeffrey Shuren, MD. Dr. Shuren's tenure was ...

Elon Musk suggested that Neuralink's brain implants could eventually be as affordable as an Apple Watch, aiming for mass ...

Precision Neuroscience, which is developing a minimally invasive brain implant, hoped to raise up to $150 million in its ...

Precision Neuroscience Corp., a brain implant rival to Elon Musk’s Neuralink Corp., has raised $93 million of a planned $100 ...

It is not known how many patients the FDA ultimately approved. Musk has grand ambitions for Neuralink, saying it would facilitate speedy surgical insertions of its chip devices to treat conditions ...

Elon Musk’s substantial support for Donald Trump’s re-election has the potential to reshape regulatory oversight across his ...

Neuralink is one of many groups working on ... a clinical study “in patients who fit the inclusion criteria,” the FDA said Tuesday. The agency pointed out that it can’t confirm or disclose ...